Data / Form D filings / Nuro Pharma Inc
Nuro Pharma Inc: Form D filings
Nuro Pharma Inc, a pharmaceuticals company in Las Vegas, NV, filed 3 Form D notices with the SEC between 2012 and 2013. The latest, on June 19, 2013, reports $79,992 sold of a $510,000 offering to 1 investor.
Find out what Nuro Pharma Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6380 POLARIS AVE UNIT B, Las Vegas, NV, 89118
- Phone
- (702) 269-1941
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506, Securities Act section 4(6)
- SEC identifier (CIK)
- 1552958
The full lists. Form D filings in Nevada: 610 rows, $30.50, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 19, 2013 | New notice | $510,000 | $79,992 | $430,008 | 1 | Jun 5, 2013 | sec.gov |
| Jul 11, 2012 | Amendment | Indefinite | $658,392 | Indefinite | 6 | Jul 2, 2012 | sec.gov |
| Jul 10, 2012 | New notice | Indefinite | $658,392 | Indefinite | 6 | Jul 2, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Albert Hansen | Director, Promoter | |
| James Fares | Executive Officer, Director, Promoter |
Every Form D from the week of Jun 17, 2013 · All recent filings in Nevada · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Nuro Pharma Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.